ZA202101342B - Compositions and methods for treating the eye - Google Patents

Compositions and methods for treating the eye

Info

Publication number: ZA202101342B
Authority: ZA; South Africa
Prior art keywords: eye; compositions; treating; methods
Prior art date: 2018-07-27

Application number

ZA2021/01342A

Inventor

Wen-Hwa Ting Li

Khalid Mahmood

Ramine Parsa

Manpreet Randhawa

Mingqi Bai

Kenneth T Holeva

Original Assignee

Johnson & Johnson Surgical Vision Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-07-27

Filing date

2021-02-26

Publication date

2023-03-29

2019-07-23 Priority claimed from US16/519,166 external-priority patent/US10966948B2/en

2021-02-26 Application filed by Johnson & Johnson Surgical Vision Inc filed Critical Johnson & Johnson Surgical Vision Inc

2023-03-29 Publication of ZA202101342B publication Critical patent/ZA202101342B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Engineering & Computer Science (AREA)
Biotechnology (AREA)
Medical Informatics (AREA)
Botany (AREA)
Alternative & Traditional Medicine (AREA)
Ophthalmology & Optometry (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Cosmetics (AREA)

ZA2021/01342A 2018-07-27 2021-02-26 Compositions and methods for treating the eye ZA202101342B (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201862703943P	2018-07-27	2018-07-27
US16/519,166 US10966948B2 (en)	2019-07-23	2019-07-23	Compositions and methods for treating the eye
PCT/IB2019/056344 WO2020021480A2 (en)	2018-07-27	2019-07-24	Compositions and methods for treating the eye

Publications (1)

Publication Number	Publication Date
ZA202101342B true ZA202101342B (en)	2023-03-29

Family

ID=68051851

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA2021/01342A ZA202101342B (en)	2018-07-27	2021-02-26	Compositions and methods for treating the eye

Country Status (9)

Country	Link
EP (1)	EP3829614A2 (en)
JP (1)	JP7374987B2 (en)
KR (1)	KR20210038635A (en)
CN (2)	CN115671090A (en)
AU (1)	AU2019311848B2 (en)
BR (1)	BR112021001092A2 (en)
CA (1)	CA3107726A1 (en)
WO (1)	WO2020021480A2 (en)
ZA (1)	ZA202101342B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA3107707A1 (en)	2018-07-27	2020-01-30	Johnson & Johnson Surgical Vision, Inc.	Compositions and methods for treating the eye
US11197841B2 (en)	2019-07-23	2021-12-14	Johnson & Johnson Surgical Vision, Inc.	Compositions and methods for treating the eye
US10966948B2 (en)	2019-07-23	2021-04-06	Johnson & Johnson Surgical Vision, Inc.	Compositions and methods for treating the eye
CN112823789B (en) *	2019-11-19	2024-05-10	强生外科视力公司	Compositions and methods for treating eyes
US11969454B2 (en)	2019-11-19	2024-04-30	Johnson & Johnson Surgical Vision, Inc.	Compositions and methods for treating the eye

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USD435966S1 (en)	1999-01-29	2001-01-09	Johnson & Johnson Vision Care, Inc.	Contact lens container
US7442391B2 (en)	2002-01-25	2008-10-28	Integrated Botanical Technologies, Llc	Bioactive botanical cosmetic compositions and processes for their production
US20030165545A1 (en)	2002-01-30	2003-09-04	Allergan, Inc.	Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
EP1722805B1 (en)	2004-01-12	2014-03-26	Akzo Nobel Surface Chemistry LLC	Bioactive compositions from theacea plants and processes for their production and use
CN101453898B (en)	2006-02-21	2014-03-26	阿克苏诺贝尔表面化学有限责任公司	Parthenolide free bioactive ingredients from feverfew (tanacetum parthenium) and processes for their production
SG172377A1 (en)	2008-12-24	2011-07-28	Ecobiotics Ltd	Plant extracts from acronychia species and their use
US20100305046A1 (en)	2009-06-02	2010-12-02	Abbott Medical Optics Inc.	Stable cyclosporine containing ophthalmic emulsion for treating dry eyes
US9480645B2 (en)	2009-06-02	2016-11-01	Abbott Medical Optics Inc.	Omega-3 oil containing ophthalmic emulsions
HUE034213T2 (en)	2009-06-05	2018-01-29	Allergan Inc	Easy and therapeutic use
CA3077331A1 (en)	2017-09-28	2019-04-04	Johnson & Johnson Consumer Inc.	Cosmetic compositions and method of treating the skin
CA3107707A1 (en)	2018-07-27	2020-01-30	Johnson & Johnson Surgical Vision, Inc.	Compositions and methods for treating the eye

2019
- 2019-07-24 WO PCT/IB2019/056344 patent/WO2020021480A2/en active Application Filing
- 2019-07-24 EP EP19773527.7A patent/EP3829614A2/en active Pending
- 2019-07-24 BR BR112021001092-0A patent/BR112021001092A2/en not_active Application Discontinuation
- 2019-07-24 AU AU2019311848A patent/AU2019311848B2/en active Active
- 2019-07-24 CN CN202211161743.8A patent/CN115671090A/en active Pending
- 2019-07-24 CN CN201980050097.8A patent/CN112888450A/en active Pending
- 2019-07-24 KR KR1020217005786A patent/KR20210038635A/en not_active Ceased
- 2019-07-24 CA CA3107726A patent/CA3107726A1/en active Pending
- 2019-07-24 JP JP2021504364A patent/JP7374987B2/en active Active
2021
- 2021-02-26 ZA ZA2021/01342A patent/ZA202101342B/en unknown

Also Published As

Publication number	Publication date
JP7374987B2 (en)	2023-11-07
WO2020021480A2 (en)	2020-01-30
AU2019311848A1 (en)	2021-01-21
JP2021533096A (en)	2021-12-02
WO2020021480A3 (en)	2020-04-30
CN115671090A (en)	2023-02-03
CN112888450A (en)	2021-06-01
CA3107726A1 (en)	2020-01-30
BR112021001092A2 (en)	2021-04-20
EP3829614A2 (en)	2021-06-09
AU2019311848B2 (en)	2024-08-01
KR20210038635A (en)	2021-04-07

Publication	Publication Date	Title
GB2578539B (en)	2022-08-10	Compositions and methods for preventing or treating muscle conditions
ZA202101362B (en)	2022-10-26	Compositions and methods for treating the eye
IL275626A (en)	2020-08-31	Surface treatment compositions and methods
ZA202101342B (en)	2023-03-29	Compositions and methods for treating the eye
SG11202103033WA (en)	2021-04-29	Compositions and methods for the treatment of presbyopia
EP3687524A4 (en)	2021-06-09	Compositions and methods for treating ophthalmic conditions
ZA202002066B (en)	2021-07-28	Compositions and methods for the treatment of eye disorders
IL271256A (en)	2020-01-30	Compositions and methods for treating tauopathies
SG11202012055PA (en)	2021-01-28	Methods and compositions for preventing or treating calciphylaxis
EP3609525A4 (en)	2020-12-30	Compositions and methods for treating or preventing gut permeability-related disorders
IL285886A (en)	2021-10-31	Compositions and methods for treating laminopathies
SG11202100675YA (en)	2021-02-25	Surface treatment compositions and methods
IL285796A (en)	2021-10-31	Methods and compositions for treating
EP3618850A4 (en)	2021-01-27	Compositions and methods for treating ocular pathologies
GB201817444D0 (en)	2018-12-12	Methods and compositions
ZA202101361B (en)	2022-10-26	Compositions and methods for treating the eye
ZA202101360B (en)	2022-07-27	Compositions and methods for treating the eye
ZA202007183B (en)	2023-01-25	Compositions and methods for treating the eye
GB202214988D0 (en)	2022-11-23	Compositions and methods for preventing or treating nephrolithiasis
PT3519050T (en)	2023-08-31	Compositions and methods for treating ophthalmic conditions
IL281002A (en)	2021-04-29	Methods and compositions for treating stroke
EP3302684A4 (en)	2020-04-01	Methods and devices for treating the cornea
IL279907A (en)	2021-03-01	Compositions and methods for treating stroke
GB201804092D0 (en)	2018-04-25	Methods and compositions
HK40052564A (en)	2022-01-21	Compositions and methods for treating the eye